Cyclohexylmethyl flavonoids suppress propagation of breast cancer stem cells via downregulation of NANOG

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Liao, Wen Ying ^a,b   Liaw, Chih Chuang ^b,c   Huang, Yuan Chao ^b   Han, Hsin Ying ^a   Hsu, Hung Wei ^d   Hwang, Shiaw Min ^e   Kuo, Sheng Chu ^b   Shen, Chia Ning ^a,b,d,f  

^a GENOMICS RESEARCH CENTER   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e FOOD INDUSTRY RESEARCH AND DEVELOPMENT INSTITUTE   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD24 ANTIGEN; CYCLOHEXYLMETHYL FLAVONOID; DOXORUBICIN; FLAVONOID; HERMES ANTIGEN; PROTEIN P53; TRANSCRIPTION FACTOR NANOG; UGONIN J; UGONIN K; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER STEM CELL; CANCER STEM CELL; CARCINOGENICITY; CELL STRAIN MCF 7; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84877290864     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/170261     Document Type: Article

References (38)

1. Amir E., Freedman O. C., Seruga B., Evans D. G., Assessing women at high risk of breast cancer: a review of risk assessment models. Journal of Natinoal Cancer Institue 2010 102 10 680 691 10.1093/jnci/djq088
2. Velasco-Velázquez M. A., Popov V. M., Lisanti M. P., Pestell R. G., The role of breast cancer stem cells in metastasis and therapeutic implication. The American Journal of Pathology 2011 179 1 2 11 10.1016/j.ajpath.2011.03.005
3. Al-Hajj M., Wicha M. S., Benito-Hernandez A., Morrison S. J., Clarke M. F., Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences 2003 100 7 3983 2988 10.1073/pnas.0530291100 (Pubitemid 36418143)
4. Liu R., Wang X., Chen G. Y., Dalerba P., Gurney A., Hoey T., Sherlock G., Lewicki J., Shedden K., Clarke M. F., The prognostic role of a gene signature from tumorigenic breast-cancer cells. The New England Journal of Medicine 2007 356 3 217 226 2-s2.0-33846425793 10.1056/NEJMoa063994 (Pubitemid 46143225)
5. Dick J. E., Breast cancer stem cells revealed. Proceedings of the National Academy of Sciences 2003 100 7 3547 3549 10.1073/pnas.0830967100 (Pubitemid 36418067)
6. - cancer cells are similarly tumorigenic. Cancer Research 2005 65 14 6207 6219 2-s2.0-22244433866 10.1158/0008-5472.CAN-05-0592 (Pubitemid 40994406)
7. Li X., Lewis M. T., Huang J., Gutierrez C., Osborne C. K., Wu M. F., Hilsenbeck S. G., Pavlick A., Zhang X., Chamness G. C., Wong H., Rosen J., Chang J. C., Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. Journal of the National Cancer Institute 2008 100 9 672 679 10.1093/jnci/djn123
8. F, Al-Ejeh, Smart C. E., Morrison B. J., Chenevix-Trench G., López J. A., Lakhani S. R., Brown M. P., Khanna K. K., Breast cancer stem cells: treatment resistance and therapeutic opportunities. Carcinogenesis 2011 32 5 650 658 10.1093/carcin/bgr028
9. Liu S., Wicha M. S., Targeting breast cancer stem cells. Journal of Clinical Oncology 2010 28 25 4006 4012 2-s2.0-77957591579 10.1200/JCO.2009.27. 5388
10. Beachy P. A., Karhadkar S. S., Berman D. M., Tissue repair and stem cell renewal in carcinogenesis. Nature 2004 432 7015 324 331 2-s2.0-9244221172 10.1038/nature03100 (Pubitemid 39551660)
11. Glinsky G. V., Stemness genomics law governs clinical behavior of human cancer: implications for decision making in disease management. Journal of Clinical Oncology 2008 26 17 2846 2853 2-s2.0-45549098737 10.1200/JCO.2008.17. 0266
12. Ben-Porath I., Thomson M. W., Carey V. J., Ge R., Bell G. W., Regev A., Weinberg R. A., An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nature Genetics 2008 40 5 499 507 2-s2.0-42649112047 10.1038/ng.127 (Pubitemid 351601215)
13. Zhang J., Wang X., Li M., Han J., Chen B., Wang B., Dai J., NANOGP8 is a retrogene expressed in cancers. FEBS Journal 2006 273 8 1723 1730 2-s2.0-33646872074 10.1002/qua.20952 (Pubitemid 43779825)
14. Ambady S., Malcuit C., Kashpur O., Kole D., Holmes W. F., Hedblom E., Page R. L., Dominko T., Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells. The International of Developmental Biology 2010 54 1743 1754 10.1387/ijdb.103192sa
15. Jeter C. R., Badeaux M., Choy G., Chandra D., Patrawala L., Liu C., Calhoun-Davis T., Zaehres H., Daley G. Q., Tang D. G., Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells 2009 27 5 993 1005 2-s2.0-66149167315 10.1002/stem.29
16. Jeter C. R., Liu B., Liu X., Chen X., Liu C., Calhoun-Davis T., Repass J., Zaehres H., Shen J. J., Tang D. G., NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation. Oncogene 2011 30 36 3833 3845 10.1038/onc.2011.114
17. Han J., Zhang F., Yu M., Zhao P., Ji W., Zhang H., Wu B., Wang Y., Niu R., RNA interference-mediated silencing of NANOG reduces cell proliferation and induces G0/G1 cell cycle arrest in breast cancer cells. Cancer Letters 2012 321 1 80 88 10.1016/j.canlet.2012.02.021
18. Bourguignon L. Y. W., Peyrollier K., Xia W., Gilad E., Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells. Journal of Biological Chemistry 2008 283 25 17635 17651 2-s2.0-47749116454 10.1074/jbc.M800109200
19. Cohen I., Tagliaferri M., Tripathy D., Traditional Chinese medicine in the treatment of breast cancer. Seminars in Oncology 2002 29 6 563 574 2-s2.0-0036969688 10.1053/sonc.2002.50005 (Pubitemid 36134979)
20. He Y., Zheng X., Sit C., Loo W. T., Wang Z., Xie T., Jia B., Ye Q., Tsui K., Chow L. W., Chen J., Using association rules mining to explore pattern of Chinese medicinal formulae (prescription) in treating and preventing breast cancer recurrence and metastasis. Journal of Translational Medicine 2012 10 supplement 1, article S12 10.1186/1479-5876-10-S1-S12
21. Huang Y. C., Hwang T. L., Chang C. S., Yang Y. L., Shen C. N., Liao W. Y., Chen S. C., Liaw C. C., Anti-inflammatory flavonoids from the rhizomes of Helminthostachys zeylanica. Journal of Natural Products 2009 72 7 1273 1278 2-s2.0-68049106360 10.1021/np900148a
22. Huang Y. C., Hwang T. L., Yang Y. L., Wu S. H., Hsu M. H., Wang J. P., Chen S. C., Huang L. J., Liaw C. C., Acetogenin and prenylated flavonoids from helminthostachys zeylanica with inhibitory activity on superoxide generation and elastase release by neutrophils. Planta Medica 2010 76 5 447 453 2-s2.0-77950237784 10.1055/s-0029-1186221
23. Suja S. R., Latha P. G., Pushpangadan P., Rajasekharan S., Evaluation of hepatoprotective effects of Helminthostachys zeylanica (L.) Hook against carbon tetrachloride-induced liver damage in Wistar rats. Journal of Ethnopharmacology 2004 92 1 61 66 2-s2.0-1942424065 10.1016/j.jep.2004.01.019 (Pubitemid 38510264)
24. Singh V., Ali Z. A., Zaidi S. T. H., Siddqui M. K., Fitoterapia 1996 Aligarh, India Department of Botany, Aligarh Muslim Universities
25. Jalil J., Bidin A. A., Chye T. S., Phytochemical study of ophyoglosaceae family species. 12 Proceedings of the Malays Biochemistry Society Conference 1986 Bangi, Malaysia Fakultas Sains Hayati Universitas Kebangsaan 160 164
26. Yu J., Vodyanik M. A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J. L., Tian S., Nie J., Jonsdottir G. A., Ruotti V., Stewart R., Slukvin I. I., Thomson J. A., Induced pluripotent stem cell lines derived from human somatic cells. Science 2007 318 5858 1917 1920 2-s2.0-36749043230 10.1126/science. 1151526
27. Boyd S. D., Tsai K. Y., Jacks T., An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Nature Cell Biology 2000 2 9 563 568 2-s2.0-0034282102 10.1038/35023500
28. Tang S. N., Singh C., Nall D., Meeker D., Shankar S., Srivastava R. K., The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition. Journal of Molecular Signaling 2010 5, article no. 14 2-s2.0-77955641868 10.1186/1750-2187-5-14
29. Sansone P., Storci G., Tavolari S., Guarnieri T., Giovannini C., Taffurelli M., Ceccarelli C., Santini D., Paterini P., Marcu K. B., Chieco P., Bonafè M., IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. Journal of Clinical Investigation 2007 117 12 3988 4002 2-s2.0-36849039660 10.1172/JCI32533 (Pubitemid 350224108)
30. Lin T., Chao C., Saito S., Mazur S. J., Murphy M. E., Appella E., Xu Y., p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nature Cell Biology 2005 7 2 165 171 2-s2.0-13944273471 10.1038/ncb1211 (Pubitemid 40268131)
31. Chambers I., Colby D., Robertson M., Nichols J., Lee S., Tweedie S., Smith A., Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003 113 5 643 655 2-s2.0-0038143611 10.1016/S0092-8674(03)00392-1 (Pubitemid 36694189)
32. Zhang J., Wang X., Li M., Han J., Chen B., Wang B., Dai J., NANOGP8 is a retrogene expressed in cancers. FEBS Journal 2006 273 8 1723 1730 2-s2.0-33646872074 10.1002/qua.20952 (Pubitemid 43779825)
33. Susanto J., Lin Y. H., Chen Y. N., Shen C. R., Yan Y. T., Tsai S. T., Chen C. H., Shen C. N., Porphyrin homeostasis maintained by ABCG2 regulates self-renewal of embryonic stem cells. PLoS One 2008 3 12 2-s2.0-58149203245 10.1371/journal.pone.0004023 e4023
34. Takao Y., Yokota T., Koide H., β -Catenin up-regulates Nanog expression through interaction with Oct-3/4 in embryonic stem cells. Biochemical and Biophysical Research Communications 2007 353 3 699 705 2-s2.0-33845996890 10.1016/j.bbrc.2006.12.072 (Pubitemid 46048726)
35. Ginestier C., Charafe-Jauffret E., Birnbaum D., p53 and cancer stem cells: the mevalonate connexion. Cell Cycle 2012 11 14 2583 2584 10.4161/cc.21092
36. Prabhu V. V., Allen J. E., Hong B., Zhang S., Cheng H., El-Deiry W. S., Therapeutic targeting of the p53 pathway in cancer stem cells. Expert Opinion on Therapeutic Targets 2012 16 12 1161 1174 10.1517/14728222.2012.726985
37. Bakkestuen A. K., Gundersen L. L., Synthesis of (+)-trixagol and its enantiomer, the terpenoid side chain of (-)-agelasine E. Tetrahedron 2003 59 1 115 121 2-s2.0-0037213031 10.1016/S0040-4020(02)01455-2 (Pubitemid 35454074)
38. Shen Y. C., Cheng S. Y., Kuo Y. H., Hwang T. L., Chiang M. Y., Khalil A. T., Chemical transformation and biological activities of ambrein, a major product of ambergris from Physeter macrocephalus (Sperm Whale). Journal of Natural Products 2007 70 2 147 153 2-s2.0-33947416024 10.1021/np068029p (Pubitemid 46447623)